Polyps (Colonic) - Symptoms, Causes, Treatment & Prevention

```html

Overview

Colonic polyps are abnormal growths that arise from the lining of the large intestine (colon) or the rectum. Most polyps are benign (non‑cancerous), but some have the potential to become cancerous over time, making early detection essential.

Who it affects: Polyps can develop at any age, but the risk rises markedly after age 45. They are slightly more common in men than women, and their prevalence varies by ethnicity (higher in African‑American and Ashkenazi Jewish populations).

Prevalence: According to the CDC, up to 25%–30% of adults aged 50‑75 have at least one colonic polyp detected during routine screening colonoscopy. In younger adults (<45 years), prevalence is lower (≈ 5%–10%) but rising, partly due to lifestyle factors and improved detection methods.

Symptoms

Many polyps cause no symptoms and are discovered incidentally during screening. When symptoms do appear, they may be vague and overlap with other gastrointestinal disorders.

• Rectal bleeding: Bright red blood on toilet paper or in the stool.
• Change in stool color: Dark, tarry stools (melena) may indicate bleeding higher in the colon.
• Altered bowel habits: New onset of constipation, diarrhea, or a feeling that the bowel does not empty completely.
• Abdominal cramping or pain: Usually mild; can become more pronounced if a large polyp causes a partial blockage.
• Unexplained weight loss: May suggest an advanced lesion or associated malignancy.
• Iron‑deficiency anemia: Chronic low‑grade bleeding can lead to fatigue, shortness of breath, and pale skin.
• Visible protrusion: Rarely, a large pedunculated polyp can be felt as a mass during a digital rectal exam.

Because symptoms are often absent, routine screening is the most reliable way to detect polyps early.

Causes and Risk Factors

What causes polyps?

The exact mechanism varies by polyp type, but most develop due to abnormal cell growth caused by genetic mutations, chronic inflammation, or environmental influences.

• Adenomatous (adenoma) polyps: Result from mutations in the APC gene and the KRAS, BRAF, or TP53 pathways, leading to uncontrolled epithelial proliferation.
• Hyperplastic polyps: Often linked to a “serrated pathway” involving BRAF mutations; typically low malignant potential.
• Inflammatory polyps: Seen in patients with long‑standing inflammatory bowel disease (IBD); arise from chronic mucosal injury.
• Hamartomatous polyps: Associated with hereditary syndromes such as Peutz‑Jeghers or Juvenile Polyposis, where germline mutations drive growth.

Who is at higher risk?

• Age ≥ 45 (risk increases with each decade).
• Male sex.
• Family history of colorectal cancer or polyps (first‑degree relative diagnosed before age 60).
• Personal history of adenomatous polyps.
• Hereditary syndromes (Lynch syndrome, Familial Adenomatous Polyposis, etc.).
• Inflammatory bowel disease (ulcerative colitis or Crohn’s disease) lasting >8‑10 years.
• Obesity (BMI ≥ 30 kg/m²) and sedentary lifestyle.
• Diet high in red or processed meat, low in fiber, calcium, and folate.
• Smoking and heavy alcohol consumption.
• Type 2 diabetes mellitus.

Diagnosis

Because most polyps are asymptomatic, screening tools are vital. The choice of test depends on patient risk, availability, and clinical presentation.

Screening & Diagnostic Tests

1. Colonoscopy (Gold standard): Direct visualization of the entire colon with the ability to remove polyps during the procedure. Sensitivity ≈ 95% for polyps ≥ 6 mm.<sup>1</sup>
2. Flexible sigmoidoscopy: Visualizes the distal 60 cm of colon; useful for low‑risk patients but may miss right‑side lesions.
3. CT colonography (virtual colonoscopy): Non‑invasive CT imaging; detects polyps ≥ 6 mm with ~90% accuracy. Requires bowel prep and may need a follow‑up colonoscopy for removal.
4. Stool‑based tests:
   • FIT (Fecal Immunochemical Test) – detects hidden blood.
   • gFOBT (guaiac‑based fecal occult blood test).
   • Multi‑target stool DNA test (e.g., Cologuard) – combines FIT with DNA markers.
   Positive results trigger colonoscopic evaluation.
5. Capsule endoscopy: Occasionally used when colonoscopy is incomplete, but limited by inability to biopsy or remove polyps.

Pathology

All removed polyps should be sent for histopathologic examination. The report classifies polyps by type (adenomatous, serrated, hyperplastic, inflammatory, hamartomatous) and assesses dysplasia grade, size, and resection margins – all critical for management planning.

Treatment Options

Endoscopic Removal

• Polypectomy: Snare or cold forceps removal during colonoscopy; preferred for polyps < 2 cm.
• Endoscopic mucosal resection (EMR): For larger (≥ 2 cm) or flat lesions; involves submucosal injection and careful resection.
• Endoscopic submucosal dissection (ESD): Allows en‑bloc removal of very large or scarred lesions; higher technical demand.

Surgical Options

Surgery is reserved for polyps that cannot be safely removed endoscopically (e.g., those with invasive cancer, large sessile lesions, or extensive familial polyposis).

• Local excision (transanal or laparoscopic).
• Partial colectomy (segmental resection).
• Prophylactic colectomy in hereditary syndromes (e.g., total colectomy for FAP).

Medication & Surveillance

• Aspirin or low‑dose NSAIDs: Evidence from the US Preventive Services Task Force suggests a modest reduction in adenoma recurrence (RR ≈ 0.72). Use only under physician guidance due to GI bleed risk.
• Calcium & Vitamin D supplementation: May lower adenoma risk; recommended 1,200 mg calcium and 800–1,000 IU vitamin D daily for at‑risk adults.
• Selective COX‑2 inhibitors (e.g., celecoxib): Shown to reduce polyp burden in FAP, but cardiovascular safety limits long‑term use.
• Statins: Observational data suggest a slight protective effect, though not yet guideline‑endorsed.

Lifestyle Modifications

Adopting a high‑fiber, low‑red‑meat diet, regular exercise, weight control, smoking cessation, and limiting alcohol can lower polyp formation and recurrence.

Living with Polyps (Colonic)

Even after removal, patients need to adopt habits that support colon health and adhere to surveillance schedules.

• Follow‑up colonoscopy: Timing depends on polyp characteristics:
  • 1–3 yr for ≥ 3 adenomas, any > 1 cm, or high‑grade dysplasia.
  • 5 yr for 1–2 small (< 1 cm) low‑risk adenomas.
• Dietary tips: Aim for ≥ 25 g fiber/day (fruits, vegetables, whole grains); incorporate legumes and nuts.
• Hydration: 8‑10 cups of water daily to promote regular bowel movements.
• Physical activity: At least 150 min of moderate‑intensity aerobic exercise per week (e.g., brisk walking).
• Medication adherence: If prescribed aspirin or calcium, take with food to minimize GI upset.
• Monitor for symptoms: Keep a log of any rectal bleeding, changes in stool, or abdominal pain and report promptly.

Prevention

Preventive strategies focus on both primary prevention (preventing polyp formation) and secondary prevention (early detection).

1. Screening: Begin average‑risk colon cancer screening at age 45 (per CDC 2023 guidelines). Choose colonoscopy every 10 years or FIT annually, based on patient preference and risk.
2. Nutrition: Follow a Mediterranean‑style diet rich in fruits, vegetables, whole grains, fish, and olive oil; limit processed meats, sugary drinks, and excess saturated fat.
3. Weight management: Maintain BMI < 25 kg/m²; even a 5% weight loss can reduce adenoma risk.
4. Physical activity: Regular exercise lowers insulin resistance, which is linked to polyp development.
5. Avoid tobacco and excess alcohol: Smoking doubles adenoma risk; limit alcohol to ≤ 1 drink/day for women, ≤ 2 drinks/day for men.
6. Consider chemoprevention: Low‑dose aspirin (81 mg) is recommended for adults 50‑59 with ≥ 10% 10‑year cardiovascular risk, after discussing GI bleed risk with a clinician.
7. Manage chronic conditions: Optimize blood glucose in diabetes, treat hyperlipidemia, and control hypertension.

Complications

If polyps are left undetected or untreated, they can lead to serious health problems:

• Colorectal cancer: Adenomatous polyps have a well‑established adenoma‑carcinoma sequence; the risk of malignant transformation increases with size > 1 cm, villous histology, and high‑grade dysplasia.
• Intestinal obstruction: Large pedunculated or sessile polyps may cause partial blockage, presenting as abdominal distention, cramping, and constipation.
• Intussusception: Rare in adults but possible when a sizable polyp acts as a lead point.
• Bleeding: Chronic low‑grade bleeding can cause iron‑deficiency anemia; acute massive bleeding, though uncommon, may require urgent intervention.
• Perforation (procedure‑related): Endoscopic removal carries a 0.1%–0.3% risk of colon wall perforation, which may need surgical repair.

When to Seek Emergency Care

References

1. American Cancer Society. Colorectal Cancer Facts & Figures 2024. https://www.cancer.org.
2. U.S. Preventive Services Task Force. Screening for Colorectal Cancer: Recommendation Statement. 2023.
3. National Cancer Institute. Colorectal Cancer Prevention (PDQ®)–Patient Version. https://www.cancer.gov.
4. Mayo Clinic. Colorectal polyps – Symptoms and causes. https://www.mayoclinic.org.
5. Cleveland Clinic. Colorectal polyp removal (polypectomy) – Procedure overview. https://my.clevelandclinic.org.
6. World Health Organization. WHO guidelines on diet, nutrition and the prevention of chronic diseases. 2022.

```